Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series
Follicular lymphoma
DOI:
10.1016/j.ijid.2024.02.016
Publication Date:
2024-02-21T16:38:47Z
AUTHORS (11)
ABSTRACT
Whilst persistent or recurrent COVID-19 infection is well described among some immunosuppressed patient cohort, to date there have been no reports of this phenomenon in the context repeatedly negative SARS-CoV-2 testing upper respiratory tract. We reported 6 follicular lymphoma developed symptomatic infection. They tested persistently for on pharyngeal swabs and ultimately confirmed by BALF metagenomics next generation sequencing. All patients presented with lymphopenia B-cell depletion, 5 them received anti-CD 20 treatment last year. Persistent fever was most common symptom bilateral ground glass opacities were primary pattern chest computed tomography. A relatively long course unnecessary ineffective antibacterial and/or antifungal treatments administered until definitive diagnosis. subsided rapidly nirmatrelvir/ritonavir treatment. Our case highlighted that should be suspected immunocompromised despite swabs, urgent necessary. Treatment appeared very effective these patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....